Clinical Trial Update: An Open-label, Single-arm Study of JWCAR201 in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma [Phase 1]

View source ↗

Summary

This document describes an open-label, single-arm Phase 1 trial evaluating the CAR-T therapy JWCAR201 in patients with relapsed or refractory diffuse large B-ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• JWCAR201

Snippet

Sponsor: Fudan University | Conditions: Diffuse Large B Cell Lymphoma | Phase 1 | Status: RECRUITING